Article
FDA Approves Seventh Denosumab Biosimilar: Richter And Hikma's Enoby And Xtrenbo
On September 29, 2025, Gedeon Richter Plc. and Hikma Pharmaceuticals Plc. along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. announced that the FDA approved their biosimilar denosumab products Enoby and Xtrenbo, referencing Prolia and Xgeva respectively.
Goodwin Procter LLP


